- World rank, all time
- #11,983 of 42,892
- Rank in Australia
- #216 of 656
- Research works
- 258 ▼ 26% vs 2013–17
- Citations
- 9.9k 38.2 per fractional work
- Top-10% rate
- 22.8% record average 16.5%
- Open access
- 45% world 28%
What is CSL (Australia) known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| Health SciencesDomain | #13,509 of 20,462 | 24.1% | 121 |
Each strip is that field’s whole ranked pool, with the notch where CSL (Australia) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 9.2×. Every wedge is a field page.
- Immunology and Microbiology 9.2×
- Biochemistry, Genetics and Molecular Biology 4.5×
- Medicine 2.2×
- Energy 1.9×
- Chemical Engineering 1.6×
- Chemistry 1.2×
- Business, Management and Accounting 0.8×
- Pharmacology, Toxicology and Pharmaceutics 0.6×
- Engineering 0.6×
- Nursing 0.6×
- Environmental Science 0.5×
- Earth and Planetary Sciences 0.4×
- Materials Science 0.3×
- Dentistry 0.3×
- Computer Science 0.3×
- Health Professions 0.2×
- Social Sciences 0.1×
- Economics, Econometrics and Finance 0.0×
Who are the top researchers at CSL (Australia)?
Ranked on the composite score, Andrew D. Nash lead among researchers whose main affiliation is CSL (Australia).
- 1 Andrew D. Nash Australia · #331,213 worldwide 123 citations · 18 works
Which keywords describe research at CSL (Australia)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Glycosylation, Monoclonal Antibodies, Therapeutic Antibodies, Cell Culture, Immunogenicity, Inflammation, Biopharmaceuticals and Antibody Engineering.
- Respiratory
- Pathogenesis
- Hemostasis
- Sustainability
- Complement
- Cancer
- Innate Immunity
- Recombinant Proteins
- Recombinant Protein
- Fc Receptors
- Biopharmaceuticals
- Cell Culture
- Inflammation
- Monoclonal Antibodies
- Glycosylation
- Therapeutic Antibodies
- Epidemiology
- Immunogenicity
- Antibody Engineering
- Mammalian Cells
- Protein Aggregation
- Genetics
- Thrombosis
- Regulation
- Immune
- Cardiovascular Disease
- Machine Learning
- Business Process Management
- Workflow Mining
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 29 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 29 words, with their numbers
- Glycosylation4▲ 103×3 topics
- Monoclonal Antibodies4▲ 122×3 topics
- Therapeutic Antibodies4▲ 145×2 topics
- Inflammation3▲ 3.9×24 topics
- Epidemiology2▲ 1.61×16 topics
- Cell Culture2▲ 52×2 topics
- Immunogenicity2▲ 137×3 topics
- Biopharmaceuticals2▲ 110×2 topics
- Antibody Engineering2▲ 97×1 topic
- Fc Receptors2▲ 97×1 topic
- Mammalian Cells2▲ 219×1 topic
- Recombinant Protein2▲ 219×1 topic
- Protein Aggregation2▲ 91×1 topic
- Recombinant Proteins2▲ 153×1 topic
- Genetics2▲ 6.2×3 topics
- Innate Immunity2▲ 14×4 topics
- Thrombosis2▲ 16×6 topics
- Cancer1▲ 2.8×8 topics
- Regulation1▲ 6.8×3 topics
- Complement1▲ 197×1 topic
- Immune1▲ 197×1 topic
- Sustainability1▲ 1.41×4 topics
- Cardiovascular Disease1▲ 2.8×11 topics
- Hemostasis1▲ 31×4 topics
- Machine Learning1◆ 0.96×5 topics
- Pathogenesis1▲ 5.7×7 topics
- Business Process Management1▲ 120×1 topic
- Respiratory1▲ 27×2 topics
- Workflow Mining1▲ 120×1 topic
Which research topics does CSL (Australia) publish most on?
By volume in 2022–2025: Monoclonal and Polyclonal Antibodies Research, Viral Infectious Diseases and Gene Expression in Insects, Protein purification and stability and Complement system in diseases.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 2 works
- 2 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 2 works
- 3 Protein purification and stability Molecular Biology 2 works
- 4 Complement system in diseases Immunology 1 works
- 5 Business Process Modeling and Analysis Management Information Systems 1 works
- 6 Coagulation, Bradykinin, Polyphosphates, and Angioedema Genetics 1 works
- 7 Influenza Virus Research Studies Epidemiology 1 works
- 8 Immune Cell Function and Interaction Immunology 0 works
- 9 Cancer, Lipids, and Metabolism Cancer Research 0 works
- 10 Platelet Disorders and Treatments Hematology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has CSL (Australia)'s research output changed?
Output in 2018–2022 was 26% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Melbourne
- The University of Melbourne
- Monash University
- La Trobe University
- RMIT University
- Swinburne University of Technology
- The Royal Melbourne Hospital
- Victoria University
- Royal Children's Hospital
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.